Phenotype-specific inhibition of the vascular smooth muscle cell cycle by high glucose treatment
β Scribed by X.-L. Zheng; S.-G. Yuan; D.-Q. Peng
- Book ID
- 105818657
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 295 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0012-186X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Repeated cycles of vascular injury by allylamine induce vascular lesions similar to those seen in atherosclerotic vessels, or following balloon catheterization. Vascular (aortic) smooth muscle cells harvested from allylamine-treated animals (i.e., allylamine cells) acquire a proliferative advantage
The testing of a 30-mer dG-rich phosphorothioate oligodeoxynucleotide (LG4PS) for effects on the behaviour of vascular smooth muscle cells (VSMC) in vitro and in vivo is described. LG4PS at 0.3 ο inhibited significantly the phenotype modulation of freshly isolated rabbit VSMC, and cell outgrowth fro
## Abstract The ability of heparin to block proliferation of vascular smooth muscle cells has been well documented. It is clear that heparin treatment can decrease the level of ERK activity in vascular smooth muscle cells that are sensitive to heparin. In this study, the mechanism by which heparin
## Abstract Restenosis is characterized by vascular smooth muscle cell (VSMC) proliferation and accumulation of collagen III in a hypertrophic and disorganized extracellular matrix. Restenosis is prevented by antimitotic agents or irradiation but no significant progress has been made to control col